THE WOODLANDS, Texas, Nov. 11, 2004 (PRIMEZONE) -- Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company, announced that its Chief Executive Officer, Steven B. Rash, was interviewed by CEOcast on November 10, 2004. CEOcast is a forum that offers Chief Executives an opportunity to communicate with investors and shareholders about the current and future plans of their organization. Topics which were covered in Mr. Rash's interview included discussions pertaining to the Company's strategic vision, current operations and plans for future growth.
Investors and other interested parties can access this interview at www.ceocast.com. Listeners can simply fill out the free registration portion of the homepage and type in PWRM to search for this interview with Mr. Rash. For more information regarding Power3 Medical Products, Inc., please visit www.power3medical.com.
Power3 Medical Products, Inc. is a leading proteomics company engaged in the discovery of protein footprints, pathways, and mechanisms of diseases. The Company's patent pending technologies are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The Company's identified protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer and neurodegenerative disease. The Company is in a strong competitive position with over 250 identified biomarkers of human disease and operates a state-of-the-art proteomics laboratory in The Woodlands, Texas.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.